Saffron

What Saffron does

Saffron Medicare Pvt. Ltd. is an Indian pharmaceutical company headquartered in Haryana, India, operating a dual business model centered on a PCD (Propaganda Cum Distribution) pharma franchise network and third-party contract manufacturing. The company manufactures and supplies a broad portfolio of generic medicines across multiple dosage forms (tablets, capsules, syrups, suspensions, injectables, ointments, creams) and therapeutic categories including antibiotics, analgesics, gynecology, dermatology, gastroenterology, orthopedics, herbal/ayurvedic preparations, dental care, and nutraceuticals. Manufacturing operations are conducted under WHO-GMP and ISO 9001 certified facilities, with multi-layered quality control covering raw material inspection, in-process checks, stability studies, and microbiological testing.

The company's primary GTM motion is the PCD franchise model, in which Saffron Medicare grants exclusive monopoly marketing rights to franchise partners operating in designated Indian territories, eliminating internal competition and enabling partners to build dominant regional presence. The franchise channel is supported with promotional materials (visual aids, brochures, visiting cards, prescription pads, MR bags) and a dedicated Android mobile application for order management. A secondary B2B revenue stream is third-party contract manufacturing, where the company produces pharmaceutical products for external brands and marketing companies under their own branding. The company operates across 12+ Indian states including Punjab, Haryana, Himachal Pradesh, Uttar Pradesh, Bihar, Karnataka, Kerala, West Bengal, Telangana, Assam, and Maharashtra, with a partner network reported at 800+ franchisees and associates.

Revenue is generated through three streams: PCD franchise rights (structured as recurring/multi-year subscriptions for territorial exclusivity), third-party contract manufacturing fees (transaction-based), and direct product sales (one-time licensing through the franchise network). The company maintains seven wholly-owned subsidiary brands (Safrovision, Dermadix, Bioraiz, Orange, Iconic, Coskin, Koro) to address distinct therapeutic or product positioning. Customer base consists primarily of small pharmaceutical distributors, stockists, medical representatives, and pharmacy owners, with no disclosed institutional anchor customers. The company is privately held with no disclosed institutional investors, no funding rounds, and no M&A activity in the available record.

Name

Saffron

Legal name

Saffron Medicare Pvt. Ltd.

Website

https://saffronmedicare.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

Saffron Medicare Pvt. Ltd. is an Indian pharmaceutical manufacturer and PCD franchise operator that produces generic medicines across multiple therapeutic categories under WHO-GMP certified facilities, serving 800+ franchise partners across 12+ Indian states and providing third-party contract manufacturing to external pharma brands.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

• Pharmaceutical manufacturing
• PCD pharma franchise
• Generic medicines
• Contract manufacturing
• Monopoly marketing rights

Headquarters

HQ city

Ambala

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. PCD Pharma Franchise: The company generates revenue through granting monopoly marketing rights to franchise partners across Indian territories. Partners pay for exclusive distribution rights and access to the company's product portfolio, enabling Saffron Medicare to expand distribution without direct investment in field sales infrastructure.
2. Third-Party Manufacturing Services: Contract manufacturing services where Saffron Medicare produces pharmaceutical products for other brands under their own brand names. Clients provide formulations and branding while Saffron handles production, quality control, and packaging.
3. Product Sales: Direct sales of pharmaceutical products through franchise network, including antibiotics, analgesics, gynecological products, dermatology range, and nutraceuticals.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Saffron Medicare Pvt. Ltd. manufactures and supplies a broad portfolio of generic pharmaceutical formulations (tablets, capsules, syrups, suspensions, injectables, ointments, creams, and nutraceuticals) under WHO-GMP and ISO certified facilities, and distributes them through a PCD pharma franchise model that grants exclusive monopoly marketing rights to partners in designated Indian territories. The company also provides third-party contract manufacturing services to other pharmaceutical brands and marketing companies. Franchise partners receive visual aids, promotional inputs, and access to a dedicated Android application to support field sales.

Product overview

Saffron Medicare is a pharmaceutical company offering a comprehensive portfolio of generic medicines across multiple therapeutic categories including antibiotics, analgesics, gynecology, dermatology, gastroenterology, orthopedics, and herbal/ayurvedic preparations. The company operates primarily as a monopoly-based PCD pharma franchise and third-party manufacturing partner, providing exclusive territorial marketing rights to franchise partners. The product portfolio includes Tablets & Capsules, Syrups & Suspensions, Injectables, Ointments & Creams, Dental Range, and Nutraceuticals. Marketing support services include Visual Aids and Promotional Inputs. The company also offers a dedicated Android mobile application for franchise partner management.

Differentiator

Problem solved

Functional benefit

Products and services

• Tablets & Capsules Pharmaceutical dosage forms manufactured in tablet and capsule formats, including antibiotics, analgesics, and anti-inflammatory medications, for distribution through franchise partners.
• Syrups & Suspensions Liquid pharmaceutical formulations including pediatric medicines, dry syrups, and suspensions for various therapeutic applications.
• Injectables Sterile injectable preparations including antibiotics, vitamins, and specialty injections for hospital and clinical use.
• Ointments & Creams Topical pharmaceutical preparations for dermatological and external applications.
• Nutraceuticals Nutritional supplements including protein powders, vitamins, and mineral supplements.
• PCD Pharma Franchise with Monopoly Rights Propaganda Cum Distribution franchise model granting exclusive territorial monopoly marketing rights to partners across India, providing access to Saffron Medicare's pharmaceutical product portfolio plus marketing support.
• Third-Party Manufacturing Contract manufacturing services where Saffron Medicare produces pharmaceutical products for other brands under their own brand names, handling production from formulation to packaging under WHO-GMP certified standards.

Quantifiable outcome

• 800+ franchise partners and associates trust Saffron Medicare for their pharmaceutical business growth
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• FDC Limited: Indian pharma manufacturer specializing in formulations across multiple dosage forms (tablets, injectables, ointments) with strong domestic franchise and third-party relationships. Similar mid-sized generics-plus-OTC portfolio and PAN India reach.
• Mankind Pharma: One of India's largest domestic-focused pharma companies with a strong PCD and franchise distribution network across antibiotics, gynae, derma and cardiovascular segments. Directly comparable business model combining branded generics manufacturing with an extensive franchise/field force across India.
• Alkem Laboratories: Mid-sized Indian pharma manufacturer with a broad generics portfolio across anti-infectives, pain, gastro and derma. Comparable in offering a wide therapeutic-range portfolio with PAN India distribution through stockists and franchise partners.
• Ajanta Pharma: India-based specialty generics manufacturer with strong domestic franchise presence in derma, ophthalmology and cardiology. Comparable therapeutic mix and India-centric distribution model with multi-dosage-form manufacturing.
• Unichem Laboratories: Indian pharma manufacturer with a broad portfolio in cardiovascular, anti-infectives and pain, distributed through a stockist/franchise model. Comparable in offering multi-therapeutic generics with deep domestic distribution.

Broad incumbents

• Lupin Limited: Major Indian generics manufacturer with strong franchise-style domestic distribution across anti-infectives, cardiology and derma. Comparable therapeutic categories and India-centric franchise GTM but at significantly larger scale.
• Torrent Pharmaceuticals: Large established Indian pharma with a broad portfolio spanning cardio, CNS, anti-infectives and derma. Overlaps with Saffron's therapeutic range but at substantially larger scale and with a more institutionalized franchise/field force.
• Cipla: One of India's largest pharma incumbents with broad generics manufacturing across multiple dosage forms. Highly comparable product mix (antibiotics, anti-infectives, derma, respiratory) but vastly larger scale, exports and brand equity than Saffron.

Emerging players

• Aligentis Pharma: Smaller Indian PCD pharma franchise and contract manufacturer with a portfolio comparable to Saffron's across tablets, syrups, injectables and derma. Closely matches Saffron's niche positioning as a regional PCD franchise player.
• Albia Biocare: India-based PCD pharma franchise and third-party manufacturer offering tablets, capsules, syrups, injectables and derma with monopoly distribution rights. Closely aligned niche peer with comparable operational model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/saffronmedicare
• Facebookfacebook.com/saffronmedicare
• LinkedInlinkedin.com/company/saffron-medicare-private-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Saffron